Decreased insulin secretion or resistance to insulin action will, therefore, affect insulin signaling in those target tissues, which may lead to impaired glucose tolerance and hyperglycemia of diabetes once β-cells are unable to compensate fully for the decreased insulin sensitivity [8]. The gene discussed is INS; the disease is Hyperglycemia.